Tierarztl Prax Ausg K Kleintiere Heimtiere 2013; 41(03): 173-179
DOI: 10.1055/s-0038-1623702
Original Article
Schattauer GmbH

Idiopathic esophagopathies resembling gastroesophageal reflux disease in dogs

Der gastroösophagealen Refluxkrankheit ähnelnde idiopathische Ösophagopathien beim Hund
M. Münster
1   Tierärztliche Gemeinschaftspraxis Dr. Hörauf und Dr. Münster, Köln
A. Hörauf
1   Tierärztliche Gemeinschaftspraxis Dr. Hörauf und Dr. Münster, Köln
A. Lübke-Becker
2   Institut für Mikrobiologie und Tierseuchen, Freie Universität Berlin
P. Grest
3   Institut für Veterinärpathologie, Vet-Suisse-Fakultät, Universität Zürich
M. Rütten
3   Institut für Veterinärpathologie, Vet-Suisse-Fakultät, Universität Zürich
› Author Affiliations
Further Information

Publication History

Received: 21 June 2012

Accepted after revision: 07 October 2012

Publication Date:
08 January 2018 (online)


ObjectivePathologic gastroesophageal reflux (GER) has been demonstrated experimentally in dogs, and it is suspected to occur naturally in dogs, yet its clinical significance is unknown. The aim of the study was to demonstrate clinical indicators of pathologic GER in dogs with idiopathic esophagopathies. Materials and methods: Dogs with clinical signs suggestive for esophageal disease (regurgitation, ptyalism, or dysphagia) and where extraesophageal and specific esophageal diseases had been ruled out, were retrospectively diagnosed with idiopathic esophagopathies. History, physical examination findings, clinicopathologic, radiographic, and endoscopic data, and treatment results were obtained from medical records, reviewed and evaluated. Results: Out of 67 dogs with anamnestic esophageal signs, 12 (17.4%) dogs were identified as having idiopathic esophagopathies and were included in the study. Median age was 3.0 years (range 1.0–11.0), and median bodyweight was 28.2 kg (range 8.2–44.0). The most frequent anamnestic esophageal signs were ptyalism (10/12 dogs), regurgitation (8/12 dogs), signs of discomfort, pain (8/12 dogs), and cough (5/12 dogs). The most common radiographic abnormality was segmental esophageal dilation (8/12 dogs). Esophagoscopy revealed single mucosal surface defects at the gastroesophageal junction in 3/12 dogs. In dogs with altered esophageal motility, cytological and microbiological examinations of bronchial aspirates showed goblet cell hyperplasia (8/8 dogs), neutrophilic infiltration (5/8 dogs) and culturable bacteria (4/8 dogs), respectively. All dogs were treated with omeprazole (median 0.7 mg/kg once per day, range 0.5-1.2). Reported median treatment duration until remission of the main clinical signs was 20.0 days (range 8.0–54.0 days). This endpoint was reached in 11/12 dogs. Conclusion and clinical relevance: Results suggest that in some dogs with esophageal clinical signs, and where no primary disease could be identified, clinical indicators of pathologic GER such as pain, mucosal lesions and motility disturbances of the esophagus, respiratory complications, and response to therapy can be observed.


Gegenstand und Ziel: Ein Vorkommen des in experimentellen Untersuchungen demonstrierten pathologischen gastroösophagealen Refluxes (PGR) wird bei natürlich erkrankten Hunden vermutet, aber die klinische Bedeutung ist unbekannt. Ziel der Studie war der Nachweis klinischer Indikatoren für PGR bei Hunden mit idiopathischen Ösophagopathien. Material und Methoden: Aufnahme in diese retrospektive Studie fanden Hunde mit ösophagealen Symptomen (Regurgitieren, Ptyalismus oder Dysphagie), bei denen extraösophageale und spezifische ösophageale Krankheiten ausgeschlossen worden waren. Diese Fälle galten als idiopathische Ösophagopathien. Ergebnisse der Anamnese, der körperlichen, labordiagnostischen, radiologischen und endoskopischen Untersuchungen sowie der Behandlungen wurden den Krankenakten entnommen und bewertet. Ergebnisse: Bei 12 von 67 (17,4%) Hunden mit ösophagealen Symptomen konnte eine idiopathische Ösophagopathie identifiziert und die Tiere in die Studie eingeschlossen werden. Das mediane Alter betrug 3,0 Jahre (Bereich 1,0–11,0), das mediane Körpergewicht 28,2 kg (Bereich 8,2–44,0). Die laut Anamnese häufigsten Symptome waren Ptyalismus (10/12 Hunde) und Regurgitieren (8/12 Hunde), ferner Unwohlsein oder Schmerzen (8/12 Hunde) und Husten (5/12 Hunde). Als häufigster Röntgen-befund lag eine segmentale ösophageale Dilatation vor (8/12 Hunde). Ösophagoskopisch ließen sich einzelne Mukosadefekte am gastroösophagealen Übergang (3/12 Hunde) darstellen. Bei Hunden mit gestörter Ösophagusmotilität zeigten zytologische und mikrobiologische Untersuchungen von Bronchialspülproben Becherzellhyperplasie (8/8 Hunde), neutrophile Infiltrationen (5/8 Hunde) und kultivierbare Bakterien (4/8 Hunde). Alle Hunde erhielten zur Behandlung Omeprazol (median 0,7 mg/kg einmal täglich, Bereich 0,5–1,3). Die Hauptsymptome gingen unter Therapie in median 20,0 Tagen (Bereich 8,0–54,0) zurück. Diesen Endpunkt erreichten 11/12 Hunden. Schlussfolgerung und klinische Relevanz: Den Ergebnissen zufolge finden sich bei Hunden mit idiopathischen Ösophagopathien ohne nachweisbare Primärkrankheiten klinische Indikatoren für PGR wie Schmerzen, ösophageale Schleimhautläsionen und Motilitätsstörungen sowie respiratorische Komplikationen, die bei adäquater Therapie sistieren.

  • References

  • 1 Adamama-Moraitou KK, Rallis TS, Prassinos NN, Galatos AD. Benign esophageal stricture in the dog and cat: a retrospective study of 20 cases. Can J Vet Res 2002; 66: 55-59.
  • 2 Allende DS, Yerian LM. Diagnosing gastroesophageal reflux disease: the pathologist’s perspective. Adv Anat Pathol 2009; 16: 161-165.
  • 3 Anderson HN, May KJ, Steinmetz GP, Ofstun M, Harrison HG, Leyse RM, Dilard DH. The lower esophageal intrinsic sphincter and the mechanism of reflux. Ann Surg 1967; 166: 102-108.
  • 4 Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 01: 85-92.
  • 5 Bexfield NH, Watson PJ, Herrtage ME. Esophageal dysmotility in young dogs. J Vet Intern Med 2006; 20: 1314-1318.
  • 6 Bissett SA, Davis J, Subler K, Degernes LA. Risk factors and outcome of bougienage for treatment of benign esophageal strictures in dogs and cats: 28 cases (1995–2004). JAVMA 2009; 235: 844-854.
  • 7 Boeckxstaens GEE. The pathophysiology of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 2007; 26: 149-160.
  • 8 Callan MB, Washabau RJ, Saunders HM, Kerr L, Prymak C, Holt D. Congenital esophageal hiatal hernia in the Chinese shar-pei dog. J Vet Intern Med 1993; 07: 210-215.
  • 9 Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a meta analysis. Am J Gastroenterol 2005; 100: 1226-1232.
  • 10 DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1984; 184: 458-468.
  • 11 Dieringer TM, Wolf AM. Esophageal hiatal hernia and megaesophagus complicating tetanus in two dogs. J Am Vet Med Assoc 1991; 199: 87-89.
  • 12 Eros G, Kaszaki J, Czobel M, Boros M. Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux. World J Gastroenterol 2006; 12: 271-279.
  • 13 Evander A, Little AG, Riddel RH. Composition of the refluxed material determined the degree of reflux esophagitis in the dog. Gastroenterology 1987; 93: 280-286.
  • 14 Farré R, Sifrim D. Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for esophageal disorders. Br J Pharmacol 2008; 135: 858-869.
  • 15 Fiocca R, Mastracci L, Riddell R, Takubo K, Vieth M, Yerian L, Sharma P, Fernström P, Ruth M. Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol 2010; 02: 223-231.
  • 16 Frapier BL. Digestive system. In: Dellmann’s Textbook of Veterinary Histology. 6th edn. Eurell JA, Frappier BL. eds. Oxford: Blackwell; 2006: 170-212.
  • 17 Favarato ES, de Souza MV, Costa PR, Pompermayer LG, Favarato LS, Ribeiro JLJunior. Ambulatory esophageal pH metry in healthy dogs with and without the influence of general anesthesia. Vet Res Comm 2011; 05: 271-282.
  • 18 Galatos AD, Raptopoulos D. Gastro-esophageal reflux during anaesthesia in the dog: the effect of age, positioning and type of surgical procedure. Vet Rec 1995; 137: 513-516.
  • 19 Galatos AD, Raptopoulos D. Gastro-esophageal reflux during anaesthesia in the dog: the effect of preoperative fasting and premedication. Vet Rec 1995; 137: 479-483.
  • 20 Gaskell CJ, Gibbs C, Pearson H. Sliding hiatus hernia with reflux oesophagitis in two dogs. J Small Anim Pract 1974; 15: 503-509.
  • 21 Gibson CJ, Parry NM, Jakowski RM, Cooper J. Adenomatous polyp with intestinal metaplasia of the esophagus (Barrett esophagus) in a dog. Vet Pathol 2010; 47: 116-119.
  • 22 Glazer A, Walters P. Esophagitis and esophageal strictures. Compend Contin Educ Vet 2008; 05: 281-292.
  • 23 Gualtieri M, Olivero D. Reflux esophagitis in three cats associated with metaplastic columnar esophageal epithelium. J Am Anim Hosp Assoc 2006; 01: 65-70.
  • 24 Gualtieri M, Cocci A, Olivero D, Monti S. Esophageal and gastric intestinal metaplasia in the dog and the cat: a retrospective study of 41 cases (2003–2007). Proceedings 18th ECVIM-CA Congress; Ghent: 2008: 217.
  • 25 Han E. Diagnosis and management of reflux esophagitis. Clin Tech Small Anim Pract 2003; 18: 231-238.
  • 26 Han E, Broussard J, Baer KE. Feline esophagitis secondary to gastro-esophageal reflux disease: clinical signs and radiographic, endoscopic, and histopathologic findings. JAAHA 2003; 39: 161-167.
  • 27 Harai BH, Johnson SE, Sherding RG. Endoscopically guided balloon dilatation of benign esophageal strictures in 6 cats and 7 dogs. J Vet Intern Med 1995; 09: 332-335.
  • 28 Hess T, Hahn EG, Konturek PC. BRAVO wireless 48 hour pH-metric system. Med Sci Monit 2009; 15: 17-21.
  • 29 Johnson HD. Active and passive opening of the cardia and its relation to the pathogenesis of hiatus hernia. Gut 1966; 07: 392-401.
  • 30 Johnson SE, Zelner A, Sherding RG. Esophageal acid clearance test in healthy dogs. Can J Vet Res 1989; 53: 244-247.
  • 31 Kiesslich R, Kanzler S, Vieth M, Moehler M, Neidig J, Thanka BJNadar, Schilling D, Burg J, Nafe B, Neurath MF, Galle PR. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis 2004; 02: 221-227.
  • 32 Kook PH, Wiederkehr D, Makara M, Reusch CE. Megaesophagus secondary to an esophageal leiomyoma and concurrent esophagitis. Schweiz Arch Tierheilk 2009; 151: 497-501.
  • 33 Leib MS, Dinnel H, Ward DL, Reimer ME, Towell TL, Monroe WE. Endoscopic balloon dilation of benign esophageal strictures in dogs and cats. J Vet Intern Med 2001; 15: 547-552.
  • 34 Miles KG, Pope ER, Jergens AE. Paraesophageal hiatal hernia and pyloric obstruction in a dog. J Am Vet Med Assoc 1988; 193: 1437-1439.
  • 35 Münster M, Bilzer T, Dettmann K, Hörauf A, Vieth M. Assessment of the histological quality of endoscopic biopsies obtained from the canine gastroesophageal junction. Tieraerztl Prax 2012; 40: 318-324.
  • 36 Osborne CA. Diagnosis by rule-out: judgement in the absence of certainty. In: Kirk’s Current Veterinar Therapy XII Small Animal Practice. Bonagura JD. ed. Philadelphia: Saunders; 1995: 11-13.
  • 37 Panti A, Bennett RC, Corletto F, Brearley J, Jeffery N, Mellanby RJ. The effect of omeprazole on oesophageal pH in dogs during anaesthesia. J Small Anim Pract 2009; 50: 540-544.
  • 38 Patrikios J, Martin CJ, Dent J. Relationship of transient lower esophageal sphincter relaxation to postprandial gastroesophageal reflux and belching in dogs. Gastroenterology 1986; 90: 545-551.
  • 39 Pearson H, Darke P, Gibs C, Kelly D, Orr C. Reflux oesophagitis and stricture formation after anaesthesia: a review of seven cases in dogs and cats. J Small Anim Pract 1978; 19: 507-519.
  • 40 Pettersson GB, Bombeck CT, Nyhus LM. The lower esophageal sphincter: mechanisms of opening and closure. Surgery 1980; 88: 307-314.
  • 41 Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut 2005; 54: 1492-1499.
  • 42 Pohl D, Tutuian R. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements. Best Pract Res Clin Gastroenterol 2009; 23: 299-311.
  • 43 Reusch C, Münster M, Kraft W. Perforierendes Ulkus als Komplikation einer Refluxösophagitis beim Hund – ein Fallbericht. Kleintierprax 1987; 32: 159-162.
  • 44 Sagawa K, Li F, Liese R, Sutton SC. Fed and fasted gastric pH and gastric residence time in conscious beagle dogs. J Pharm Sci 2009; 98: 2494-2500.
  • 45 Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003; 98: 1487-1493.
  • 46 Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 05: 1392-1399.
  • 47 Strombeck DR, Harold D. Effects of atropine, acepromazine, diazepam, meperidine, and xylazin on gastroesophageal sphincter pressure in the dog. Am J Vet Res 1985; 46: 963-965.
  • 48 Szentpali K, Eros G, Kaszaki J, Tiszlavicz L, Lázár G, Wolfárd A, Balogh A, Boros M. Microcirculatory changes in the canine esophageal mucosa during experimental reflux esophagitis: comparison of the effects of acid and bile. Scand J Gastroenterology 2003; 38: 1016-1022.
  • 49 Tolbert K, Bissett S, King A, Davidson G, Papich M, Peters E, Degernes L. Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs. J Vet Intern Med 2011; 25: 47-54.
  • 50 Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal injury: a review of animal and human studies. Gastroenterology 1995; 108: 1897-1907.
  • 51 Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900.
  • 52 Van Nieuwenhove Y, Willems G. Gastroesophageal reflux triggers proliferative activity of the submucosal glands in the canine esophagus. Dis Esophagus 1989; 11: 89-93.
  • 53 Vieth M. Structural abnormalities of endoscopy-negative reflux disease – real or perceived?. Digestion 2008; 78: 24-30.
  • 54 Waterman AE, Hashim MA. Measurement of the length and position of the lower oesophageal sphincter by correlation of external measurements and radiographic estimations in dogs. Vet Rec 1991; 129: 261-264.
  • 55 Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol Suppl 1989; 156: 7-13.
  • 56 Wilson DV, Walshaw R. Post anaesthetic esophageal dysfunction in 13 dogs. J Am Anim Hosp Assoc 2004; 40: 455-460.
  • 57 Wilson G. Ulcerative esophagitis and esophageal stricture. J Am Anim Hosp Assoc 1977; 13: 180-185.